Piperidine compounds useful as PPAR activators
US7199243B2 · kind B2 · utility
0Cited by
13References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 24, 2003 |
| Grant date | Apr 3, 2007 |
| Priority date | — |
| Expiry date | Oct 29, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.